FDA Appoints Laughren Director of New Psychiatry Products Division

Drug Industry Daily
KEYWORDS FDA / People
A A

The FDA has appointed Thomas Laughren director of the newly formed Division of Psychiatry Products within the Office of Drug Evaluation I.

To View This Article:

Login

Subscribe To Drug Industry Daily